Clinical Study on the Evaluation of the Efficacy of Cervical Cancer

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Feb 4, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving the treatment and monitoring of cervical cancer. Researchers aim to create a new model that combines various types of patient data—like imaging results, genetic information, and even the makeup of gut bacteria—to better predict how cervical cancer might progress and what side effects patients might experience from their treatments. By understanding these factors, the goal is to provide more personalized care, helping doctors identify the best treatment options and catch any signs of the cancer returning as early as possible.

To participate in this trial, women aged 65 and older with a confirmed diagnosis of cervical cancer may be eligible, especially if they have not received radiation therapy or other treatments yet. Participants can expect to provide various health information and undergo assessments that will help develop tools for better predicting outcomes in cervical cancer. It's important to note that this study is not currently recruiting participants, but it represents a significant step toward enhancing care for those affected by cervical cancer.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pathology: patients with pathologically confirmed cervical cancer
• • Location: primary tumor of the cervix
• Exclusion Criteria:
• • Patients with no prior radiation therapy
• • Patients without treatment
• • Patients without regular follow-up